Skip to main content
Press release July 16, 2026

Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026

Zymeworks Inc. (ZYME)

VANCOUVER, British Columbia, July 16, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will report its
View original release